Seattle, WA, United States of America

Anthony E Namen


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 144(Granted Patents)


Location History:

  • Seattle,, WA (US) (1990)
  • Seattle, WA (US) (1994 - 2000)

Company Filing History:


Years Active: 1990-2000

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Anthony E Namen

Introduction

Anthony E Namen is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic cell proliferation. With a total of 6 patents to his name, Namen's work has had a profound impact on medical science.

Latest Patents

Namen's latest patents focus on the use of interleukin-7 to stimulate the proliferation of hematopoietic cells. His patents include the development of mammalian interleukin-7 proteins (IL-7s), DNAs, and expression vectors encoding these proteins. Additionally, he has disclosed processes for producing mammalian IL-7s as products of cell culture, including recombinant systems. These innovations are crucial for advancing therapeutic applications in medicine.

Career Highlights

Throughout his career, Anthony E Namen has worked with prominent companies in the pharmaceutical industry. Notable among these are Immunex Corporation and Sterling Winthrop Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Namen has collaborated with esteemed colleagues in his field, including Raymond G Goodwin and Stephen D Lupton. These partnerships have fostered a collaborative environment that has led to significant advancements in their shared research interests.

Conclusion

Anthony E Namen's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…